Literature DB >> 9147454

[Adaptation and normalization of the Alzheimer's disease Assessment Scale for Spain (NORMACODEM) (II)].

J Peña-Casanova1, M Aguilar, P Santacruz, I Bertran-Serra, G Hernández, J M Sol, A Pujol, R Blesa.   

Abstract

UNLABELLED: This report is part of a project for norming cognitive and functional instruments that assess dementia (NORMACODEM). To adapt and norm the Alzheimer's Disease Assessment Scale (ADAS) for use in Spain. Two hundred fifty-four controls, 86 patients with minor memory/cognitive disorders without dementia (deterioration without dementia, DWD), 111 patients with Alzheimer-type dementia (ATD). Statistical description. Multivariate linear regression. Crossed validation. Internal consistency and test-retest (n = 48). The mean scores (SD) obtained were as follows. CONTROLS: ADAS-Cog = 8.0 (3.4), ADAS-Noncog = 2.9 (2.9), ADAS-Tot = 10.9 (4.6). DWD: ADAS-Cog = 11.37 (5.1), ADAS-Noncog = 4.9 (4.3), ADAS-Tot = 16.2 (7.0). ATD: ADAS-Cog = 31.8 (5.1), ADAS-Noncog = 10.3 (4.3), ADAS-Tot = 42.2 (20.7). Multiple regression analysis revealed that educational level and age were significantly associated with the ADAS-Cog score. The internal consistency of the ADAS-Cog was 0.963. The test-retest procedure yielded linear correlation, coefficients of 0.93 for the ADAS-Cog, 0.86 for the ADAS-Noncog and 0.95 for the ADAS-Tot. Age and educational level/schooling are associated to the earned on the ADAS-Cog instrument. The present Spanish version of the ADAS has high internal consistency and reproducibility. The instruments can be use for assessment in Spanish populations.

Entities:  

Mesh:

Year:  1997        PMID: 9147454

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  6 in total

1.  Normative data of a brief neuropsychological battery for Spanish individuals older than 49.

Authors:  Montserrat Alegret; Ana Espinosa; Georgina Vinyes-Junqué; Sergi Valero; Isabel Hernández; Lluís Tárraga; James T Becker; Mercè Boada
Journal:  J Clin Exp Neuropsychol       Date:  2011-12-13       Impact factor: 2.475

2.  From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery.

Authors:  Montserrat Alegret; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Isabel Hernández; Marta Marquié; Maitée Rosende-Roca; Ana Mauleón; Carla Abdelnour; Liliana Vargas; Ester Esteban de Antonio; Rogelio López-Cuevas; Juan Pablo Tartari; Emilio Alarcón-Martín; Lluís Tárraga; Agustín Ruiz; Mercè Boada; Sergi Valero
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

3.  Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment.

Authors:  Manuel Fernández; Ana L Gobartt; Montse Balañá
Journal:  BMC Neurol       Date:  2010-09-28       Impact factor: 2.474

4.  Cut-off scores of a brief neuropsychological battery (NBACE) for Spanish individual adults older than 44 years old.

Authors:  Montserrat Alegret; Ana Espinosa; Sergi Valero; Georgina Vinyes-Junqué; Agustín Ruiz; Isabel Hernández; Maitee Rosende-Roca; Ana Mauleón; James T Becker; Lluís Tárraga; Mercè Boada
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

5.  The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2.

Authors:  Juan Domingo Gispert; Gemma C Monté; Marc Suárez-Calvet; Carles Falcon; Alan Tucholka; Santiago Rojas; Lorena Rami; Raquel Sánchez-Valle; Albert Lladó; Gernot Kleinberger; Christian Haass; José Luis Molinuevo
Journal:  Alzheimers Dement (Amst)       Date:  2016-12-22

6.  Cognitive and affective assessment in day care versus institutionalized elderly patients: a 1-year longitudinal study.

Authors:  Ana Maseda; Aránzazu Balo; Laura Lorenzo-López; Leire Lodeiro-Fernández; José Luis Rodríguez-Villamil; José Carlos Millán-Calenti
Journal:  Clin Interv Aging       Date:  2014-06-05       Impact factor: 4.458

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.